SHUKHRAT BOYMURADOV,ERGASHEV RASULBEK SOKHIBUGLI,HAIDER MOHAMMED ABBAS ,C R RAMANATHAN, GMDSS ,MS. AKANKSHA DUBEY
DOI: https://doi.org/Despite making up over 70% of the planet's surface, marine-derived microbial natural products have not yet been fully utilized. The marine ecosystem is home to a wide variety of exotic microorganisms that create bioactive chemicals in order to survive in particular environmental niches. In the development of cross-relationships between bacteria and their eukaryotic hosts, chemically mediated interactions are also crucial. In these interactions, organisms that produce antimicrobials (also known as "antimicrobials") may prevent the host surface from becoming over-colonized in exchange for an environment that is rich in nutrients. A number of obstacles, including unsuitable growth conditions, time-consuming purification procedures, and ineffective de-replication, have impeded the finding and characterisation of marine microbial bioactive, as has been the case with the discovery of bioactivity generally. Improved microbial cultivation technologies, microbial (meta-)genomics, and new sensitive structural elucidation tools are progressively overcoming them. Here, we outline how future discoveries and developments of new medications derived from marine microbes will unavoidably increase as a result of these technological advancements and our growing understanding of microbial and chemical ecology.
